ARDX · Ardelyx Inc
United States · RS rating 10 · As of 2026-10-14
| Price | 3.19 USD |
|---|---|
| 1-day change | +2.2% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 33 / 8 / 19 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 6 / 44 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +53.3% |
| Sales growth Q/Q | +13.5% |
| Distance from 52-week high | +60.1% |
| Market cap (USD) | $1.5B |